Plain-English translation of NCT06881238 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether having hepatitis B infection changes how inflammatory bowel disease develops and behaves in Egyptian patients. This is an observational study, meaning doctors will review your medical history, test results, and imaging to compare outcomes between patients with and without hepatitis B. The goal is to learn whether having both conditions together affects disease severity, hospital visits, or treatment needs.
Inflammatory bowel disease and hepatitis B are both serious conditions that can affect the liver and digestive system, but doctors don't fully understand how they interact when someone has both. This study aims to fill that gap by examining whether hepatitis B infection makes inflammatory bowel disease harder to control or more severe.
You likely qualify if…
You likely don't qualify if…
Researchers will review your medical records, including your history of hospital stays, disease flare-ups, surgeries, and medications. You will undergo a physical examination, blood tests, abdominal ultrasound, and possibly an endoscopy (a camera procedure to look inside your digestive tract). This is a retrospective study, meaning doctors will primarily look at information already in your medical records rather than asking you to visit repeatedly.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
Egypt
Enrollment target
~162 participants
Started
December 2024
Primary completion
May 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rania M Elkafoury, MD
Tropical medicine and infectious diseases Department, Faculty of Medicine, Tanta University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.